Biogen Inc. (BVMF:BIIB34)
161.80
-0.20 (-0.12%)
At close: Feb 5, 2026
Biogen Market Cap
Biogen has a market cap or net worth of 154.11 billion as of February 6, 2026. Its market cap has increased by 24.37% in one year.
Market Cap
154.11B
Enterprise Value
166.68B
Revenue
54.48B
Ranking
n/a
PE Ratio
21.64
Stock Price
161.80
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 149.34M to 154.11B, an increase of 103,091.21%. That is a compound annual growth rate of 22.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 154.11B | 8.37% |
| Dec 31, 2025 | 142.21B | 3.18% |
| Dec 31, 2024 | 137.82B | -24.25% |
| Dec 29, 2023 | 181.94B | -13.70% |
| Dec 30, 2022 | 210.81B | 7.36% |
| Dec 31, 2021 | 196.36B | 0.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 91.65B |
| Raia Drogasil | 46.56B |
| Hypera | 14.97B |
| Fleury | 9.23B |
| Odontoprev | 6.46B |
| Diagnósticos da América | 5.27B |
| Empreendimentos Pague Menos | 4.17B |
| Oncoclínicas do Brasil Serviços Médicos | 2.77B |